FDA recommends label updates for some immunosuppressants

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1261, 2009-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FDA recommends against off-label sildenafil use in children

Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The US FDA has made updates to the Revlimid [lenalidomide] label, similar to those announced recently by Health Canada.

Reactions Weekly, Vol. 1, Iss. 1402, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

FDA recommends changes to TNF antagonist labels

Reactions Weekly, Vol. 1, Iss. 1265, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Institute of Medicine recommends US FDA reforms

Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

GSK updates Avandia label for Canada

Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite